In this retrospective study, we analyzed prognostic factors associated with survival outcomes in 73 locally advanced gastric cancer patients treated with neoadjuvant chemotherapy (NAC) followed by surgical resection. Median diseasefree survival (DFS) for 64 patients that received R0 resection was 685 days, whereas median overall survival (OS) for 73 patients was 930 days. Multivariate analysis demonstrated that post-treatment nodal stages (P = 0.002), nervous invasion (P = 0.0492) and serum CA199 levels (P = 0.0398) were independent prognostic factors for DFS. Nodal stages (P = 0.0007), presence of nervous invasion (P = 0.0259) and non-radical resection (P = 0.0165) were independent prognostic factors for OS. These results indicate that post-treatment nodal stages, neural invasion and serum CA199 levels are all associated with poor DFS. Moreover, post-treatment nodal stage, resection type and neural invasion status are independent prognostic factors for OS.
INTRODUCTION
Gastric cancer ranks fifth among most malignant cancers and third among cancer related deaths worldwide [1] . China has the highest incidence of gastric cancer accounting for 35% of total gastric cancer cases worldwide with a high mortality rate of 25.16 cases per 100,000 [2] . Prognosis of locally advanced gastric cancer is poor with a 5-year overall survival (OS) rate of20-30% for surgery-only patients [3] . Neoadjuvant chemotherapy (NAC) is preferred for locally advanced gastric cancer patients since the release of the MRC Adjuvant Gastric Infusional Chemotherapy (MAGIC) trial results [4] . Many studies demonstrate that NAC reduces the size of gastric cancer lesions thereby decreasing tumor staging and increasing the chances for radical resection and survival while decreasing post-operative complications [5] [6] [7] [8] [9] . However, standard regimen and courses of NAC are not yet established and prognostic factors associated with survival outcomes for patients treated with NAC followed by surgery remain unclear.
Therefore, we analyzed the relevant prognostic factors associated with survival by reviewing medical records of 73 locally advanced gastric cancer patients that were treated with neoadjuvant chemotherapy followed by curative-intent surgery. Our analysis included the prognostic status of pathological response to NAC and post-therapy node status (Nodal stage or lymph node metastasis ratio). 
RESULTS

Patient and treatment characteristics
Prognostic factors associated with disease-free survival
Median DFS for 64 patients that received R0 resection was 685 days (Figure 1 ). Univariate analysis showed that nodal stages, lymph node metastasis ratio and nervous invasion were prognostic factors associated with DFS ( No 65
* Tumor response to NAC was not evaluated for 3 patients; 2 of them developed ileus during treatment, and the other one missed assessment for personal reasons. ‡/ § vascular invasion and nervous invasion status were not reported for one patient. ║51 patients were administered post-surgery chemotherapy and had medical records in our hospital;The post-surgery chemotherapy records of 22 patients was not known. ¶ 8 patients received post-operative radiotherapy. 
0022). Patients with nervous invasion
showed lower DFS (185 days) than patients without nervous invasion (821 days; P=0.0139).Furthermore, vascular invasion and elevated serum CA199 levels were marginally associated with shorter DFS (P = 0.0666 and P = 0.0613, respectively). Multivariate analysis by stepwise Cox model showed that post-treatment nodal stage, nervous invasion and serum CA199 levels were independent prognostic factors for DFS (Table 3 ). Higher N stages [N1 (HR =2.028, 95% CI = 0.604-6.808), N2 (HR = 0.812, 95%CI = 0.187-3.530), and N3 (HR = 7.044, 95% CI = 2.189-22.666), P=0.002], nervous invasion (HR = 3.647; 95% CI = 1.004-13.242; P=0.0492), elevated serumCA199(HR = 2.540; 95% CI = 1.044-6.176; P=0.0398) levels showed significant association with shorter DFS. In contrast, lymph node metastasis ratio and presence of vascular invasion were not associated with DFS according to multivariate analysis.
Prognostic factors associated with overall survival
Kaplan-Meier survival analysis showed a median OS of 930 days (Figure 2 ). Univariate analysis for OS showed that nodal stage (N), lymph node metastasis ratio (NR), nervous invasion, resection type and serum CEA/ CA199ratiowere prognostic indicators of OS, whereas, graded pathologic response and presence of vascular invasion showed marginal association with OS (Table 2) . (Table 4) .
DISCUSSION
Patients with potentially resectable gastric cancer are treated with neoadjuvant chemotherapy to improve survival. However, a standard regimen is not clear. Several investigations have shown that patients that received NAC followed by surgery, age at diagnosis, post-treatment nodal status, diffuse-type histology, perineural invasion/vascular invasion and salvage surgery are associated with OS [10] [11] [12] [13] . Our study demonstrated that clinical response (SD or PR) was not a significant prognosis factor for DFS or OS. One possible reason is that we enrolled only limited number of patients that underwent curative-intent surgery after NAC.
The prognostic value of pathologic response to neoadjuvant chemotherapy remains controversial although it has been investigated for various malignancies. Kurokawa Y et al. suggested that pathological response was a better surrogate endpoint than RECIST in neoadjuvant chemotherapy for gastric cancer [14] . In many studies, univariate analysis showed that pathologic response was a predictor of survival in GC patients after receiving neoadjuvant chemotherapy; but, multivariate analysis showed that it was not an independent predictor of OS [10, [15] [16] [17] [18] . In this study, univariate analysis showed that pathologic response was marginally associated with OS, but not associated with DFS; multivariate analysis showed that it was not associated with both DFS and OS. Fujitaniet al. showed that pathologic response was associated with OS in the subset of patients with nodal stages N0-1 [10] .Therefore, further prospective studies with larger sample size are necessary to confirm the prognostic status of pathologic response in patients that undergo curative-intent surgery after NAC. Metastatic lymph node ratio (NR) is an alternate prognostic factor instead of the number of lymph nodes (N in TNM staging) in GC because of the limited number of lymph nodes [18, 19] . Persiani R et al. showed that TRM (R means metastatic lymph node ratio) staging system had better prognostic power than the TNM system by reviewing 219 patients that underwent gastrectomy [21] . In the present study, NR was a prognostic factor for both DFS and OS in univariate analysis, but was in significant in multivariable analysis. However, posttreatment N stage showed association with DFS and OS in both univariable and multivariable analyses, consistent with the study by Fujitani et al. [10] .Therefore, posttreatment N stage was a more reliable prognostic factor than metastatic lymph node ratio (NR) in locally advanced GC patients that received gastrectomy after NAC. Changes in serum CA199 levels demonstrate therapeutic efficacy with increased serum CA199 levels indicating treatment failure or recurrence. Mohri et al. showed thatCA199 was an independent prognostic factor for OS in patients with metastatic gastric cancer [22] . Schauer et al demonstrated that serum CA199 levels predicted survival in patients with diffuse type gastric cancer after surgical treatment [23] . Zhu et al showed that serum CA199 was part of the prognostic index for patients with metastatic gastric cancer that received epirubicin (EPR)-containing triplet regimen as first-line treatment [24] . In our study, univariate analysis showed that elevated serumCA199 levels were associated with both shorter DFS and OS, but multivariate analysis showed that it was associated with poor DFS. This suggested that serum CA199 levels were strong predictors of long-term survival inGC patients.
Our findings are limited because this was a retrospective study conducted in a single institution with few select patients (73 study subjects) with different preand post-operative chemotherapeutic regimens. Larger multi-center prospective studies are necessary to confirm our findings.
In conclusion, our study demonstrates that posttreatment nodal stages, neural invasion and serum CA199 levels are associated with poor DFS. Moreover, posttreatment nodal stage, resection type and neural invasion status are independent prognostic factors for OS. This study also revealed that post-treatment N stage was a more reliable prognostic factor than metastatic lymph node ratio (NR) in locally advanced GC patients that received gastrectomy after NAC.
MATERIALS AND METHODS
Patients and treatment schedule
We retrospectively analyzed the outcomes of 73 consecutive patients with locally advanced gastric cancer that were treated with neoadjuvant chemotherapy 
Statistical analysis
SAS statistical software 9.3 (SAS Institute Inc., Cary, NC, USA) was used for all statistical analyses. Overall survival (OS) was defined as the time from the date of initiation of NAC until death from any cause (event) or the last follow-up date (censored). Disease-free survival (DFS) was defined as the time from the date of surgery until local or distant relapse was detected (event) or the last follow-up date (censored). Kaplan Meier survival analysis was used to determine both DFS and OS.
Univariate analyses were performed by the log rank test for the following variables: age at diagnosis (≥ 60 vs. ≤ 60); gender (male vs. female); abnormal versus normal levels of serum CEA, CA199and CA724; Neoadjuvant chemotherapy regimen [doublet (Fluoropyrimidine + Platinum) versus triplet (Fluoropyrimidine + Platinum + Anthracyclines or Taxane)]; clinical response (partial response vs. stable disease); graded pathologic response (minor vs. moderate vs. major); resection type (R0 vs. R1+R2); Nodal stage [N0 (no metastasis), N1 (1-2 metastatic nodes), N2 (3-6 metastatic nodes), or N3 (7 or more metastatic nodes)]; lymph node metastasis ratio [number of positive nodes/number of nodes examined and classified as NR0 (0%), NR1 (<15%), NR2 (15-40%), or NR3 (>40%)];presence or absence of vascular invasion; presence or absence of nervous invasion; and if regimen of AC was the same as NAC or not.
Multivariate analysis of prognostic factors was performed by the stepwise Cox proportional hazard model with the variables identified as significant factors in the univariate analyses and hazard ratio (HR) and their95% confidence intervals (CIs) were calculated. A two-sided P < 0.05 was considered statistically significant.
